138385-34-9

Upstream product

• 138511-91-8 2',3',5'-tri-O-benzyl-1'-deoxy-1'-phenyl-β-D-ribofuranose 
• 591-51-5 phenyllithium 
• 118436-92-3 1-phenyl-2,3,5-tri-O-benzyl-D-arabinofuranose 
• 14233-64-8 tri-O-benzyl-D-arabinolactone 
• 118436-94-5 β-1-phenyl-1-deoxy-2,3,5-tri-O-benzyl-D-arabinofuranose 
• 138385-32-7 (R)-2,3,5-tri-O-benzyl-1-C-phenyl-D-ribitol 
• 16838-89-4 2,3,5-tri-O-benzyl-D-ribofuranose 

Downstream Products

• 118436-95-6 tetra-O-acetyl-1-deoxy-1-phenyl-D-ribitol 
• 118436-95-6 1,2,3,4-tetraacetoxy-5-phenyl-(2R,3S,4R)-pentane 

Relevant academic research and scientific papers

Synthesis and cytotoxic activity of C-glycosidic nicotinamide riboside analogues

The C-glycosidic nicotinamide riboside analogue (2) was prepared by reaction of ribonolactone 24 with the lithiated oxazoline 19 followed by triethylsilane reduction to 26 and deprotection. Selective phosphorylation to the pseudonucleotide 34 was effected

C-Glycosides. 7. Stereospecific C-Glycosylation of Aromatic and Heterocyclic Rings

Stereospecific C-glycosylation of aromatic and heterocyclic rings can be realized by reacting the corresponding organolithium derivatives with benzylated lactones and reducing the so-obtained lactols with triethylsilane in the presence of boron trifluorid